EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Immune Checkpoint Inhibitors in Breast Cancer: Mechanisms, Biomarkers, and Future Therapeutic Strategies

Qiu-Chan Deng, Wen-Bin Kuang, Yu-Jing Yang, Cai-Ping Gong, Yi-Peng Zhang, Qiong Luo, Liu-Ping Luo, Guang-Ming Wang iD

Therapeutics and Clinical Risk Management · 2026-07 · Volume 22 · 1-17

DOI: 10.2147/tcrm.s547154 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Therapeutics and Clinical Risk Management, 2026-07. Verfasst von Qiu-Chan Deng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Shenzhen Longhua District Central Hospital, Shenzhen, Guangdong, 518110, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

biomarkersbreast cancerimmune checkpoint inhibitorsimmunotherapyresistance mechanismstumor microenvironment

Autor:innen und Institutionen

  • Department of Clinical Laboratory, Shenzhen Longhua District Central Hospital, Shenzhen, Guangdong, 518110, People's Republic of China.
  • Laboratory Medicine, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, 510080, People's Republic of China.
  • Department of Hematology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, 510080, People's Republic of China.
  • Department of Administrative, Shenzhen Longhua District Central Hospital, Shenzhen, Guangdong, 518110, People's Republic of China.

ORCID-Profile: Guang-Ming Wang

Zitieren

APA

Deng, Q. C., Kuang, W. B., Yang, Y. J., Gong, C. P., Zhang, Y. P., Luo, Q., Luo, L. P., & Wang, G. M. (2026). Immune Checkpoint Inhibitors in Breast Cancer: Mechanisms, Biomarkers, and Future Therapeutic Strategies. Therapeutics and Clinical Risk Management, Volume 22, 1-17. https://doi.org/10.2147/tcrm.s547154

Vancouver

Deng QC, Kuang WB, Yang YJ, Gong CP, Zhang YP, Luo Q, et al. Immune Checkpoint Inhibitors in Breast Cancer: Mechanisms, Biomarkers, and Future Therapeutic Strategies. Therapeutics and Clinical Risk Management. 2026;Volume 22:1-17. doi:10.2147/tcrm.s547154

BibTeX
@article{Deng2026,
  author = {Deng, Qiu-Chan and Kuang, Wen-Bin and Yang, Yu-Jing and Gong, Cai-Ping and Zhang, Yi-Peng and Luo, Qiong and Luo, Liu-Ping and Wang, Guang-Ming},
  title = {Immune Checkpoint Inhibitors in Breast Cancer: Mechanisms, Biomarkers, and Future Therapeutic Strategies},
  journal = {Therapeutics and Clinical Risk Management},
  year = {2026},
  volume = {Volume 22},
  pages = {1--17},
  doi = {10.2147/tcrm.s547154}
}
Kostenlos starten →